kras mutation and glutathion JCI KRAS-targeted therapies in cancer: novel
KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology kras mutation and glutathion glynac Interplays of glucose metabolism in pancreatic ductal adenocarcinoma GlyNAC Supplementation Improves Glutathione Deficiency, The roles of KRAS in cancer metabolism, tumor microenvironment and clinical therapy PMC Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma Cell Death & Disease Metabolic networks in mutant KRAS driven tumours: tissue specificities and the microenvironment Nature Reviews Cancer
Pay in 4 interest-free payments of $7.10 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




